264 filings
Page 4 of 14
8-K
pznlm
21 Oct 21
Other Events
8:32am
8-K
v55u7
18 Oct 21
Departure of Directors or Certain Officers
9:06am
8-K
b14j9be0syfm7cs7c51q
8 Oct 21
Other Events
5:03pm
8-K
bwodbn4nbfkaoeivdj
5 Oct 21
Departure of Directors or Certain Officers
4:06pm
8-K
0dmmcr0d wp0b
21 Sep 21
Other Events
4:24pm
8-K
3d4f0 9a6qr
8 Sep 21
Business separation of bluebird and 2seventy expected to be completed in October 2021
7:33am
8-K
79zw2w wy
7 Sep 21
Gina Consylman appointed chief financial officer, severe genetic disease
4:09pm
8-K
84fqqi3t
9 Aug 21
Results of Operations and Financial Condition
7:02am
8-K
qyb9aim ivdgl
28 Jul 21
Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies
8:04am
8-K
ey5j51vq6oq ynrgdfb
21 Jul 21
SKYSONA is the first and only gene therapy approved in the EU to treat early CALD
6:30am
8-K
s9rr vn13
9 Jul 21
Other Events
7:38am
8-K
v88gfi
17 Jun 21
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
cdgq296 ww2
11 Jun 21
Other Events
6:15am
8-K
ids4s 2uzbm
7 Jun 21
Other Events
8:07am
8-K
ibod wjw1b1
21 May 21
SKYSONA is the first and only gene therapy recommended for approval for patients with CALD, a progressive, neurodegenerative disease
8:33am
8-K
nd5grlwl885pn1i
19 May 21
Data from pivotal KarMMa study to be presented at ASCO21 show 24.8-month median overall survival in triple-class exposed multiple myeloma
5:06pm
8-K
tur643ti
5 May 21
Results of Operations and Financial Condition
4:10pm
8-K
mhpz4
20 Apr 21
In the Court of Chancery of the State of Delaware
4:10pm
8-K
6seadr
20 Apr 21
Other Events
7:41am
8-K
ewf4jn5vdmjbnv
29 Mar 21
Other Events
6:11am